Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 834 results for "myers"

Bristol-Myers : Primary Endpoints Met In ALLY-1 Trial - Quick ...

Bristol-Myers Squibb Co. (BMY: Quote) announced that primary endpoints were successfully met in ALLY-1, a Phase III clinical trial evaluating a 12-week regimen of daclatasvir and sofosbuvir once-daily with ribavirin for the treatment of patients ... RTTNews.com, 5 hours ago

6,651 images for myers

Playboy, 6 hours ago
Merced Sun-Star, 1 day ago
Raleigh News & Observer, 1 day ago
Raleigh News & Observer, 1 day ago
Tampa Bay Times, 4 hours ago
Melbourne Age, 7 hours ago
Channel24, 1 day ago
Kingston Whig-Standard, 5 hours ago
Canberra Times, 1 day ago
KansasCity.com, 3 days ago

Bristol Myers (BMY) Trading Near $66.63 Resistance Level

After FridayaEUR(TM)s trading in Bristol-Myers Squibb Co (http://www.marketintelligencecenter.com/symbol/BMY"BMY) MarketIntelligenceCenter.com's patented algorithms uncovered a trade that offers a 2.86% return or 19.73% on an annualized basis (for ...
 Individual.com22 minutes ago Bristol Myers (BMY) Showing Bullish Technicals With Resistance At $66.74  Individual.com2 days ago

ISS Backs Activist Trian Getting Two Board Seats at DuPont -- Update

Institutional Shareholder Services Inc. said Monday that DuPont shareholders should elect Mr. Peltz and John Myers, two of the four nominees Mr. Peltz's Trian Fund Management LP had put forward. "This is not a broken company--but there is ...
 Morningstar.com1 hour ago Proxy Advisor Sides With Trian Management's Peltz In DuPont Fight  Forbes.com1 hour ago
[x]  
Reuters

Bristol-Myers Squibb Release: ALLY-1 Trial Results Show Investigational Daclatasvir-Based Regimen Cures 94% Of Post-Liver Transplant Patients With Hepatitis C And Up To 94% Of Hepatitis C Patients With Cirrhosis (Child-Pugh Class A Or B)

97% of post-transplant patients with HCV genotype 1a achieved cure 91% of post-transplant patients with HCV genotype 3 achieved cure No need seen to alter existing transplantation medication regimens PRINCETON, N.J.--( BUSINESS ...
 BioSpace1 hour ago High Hep C Cure Rate for Daclatasvir and Sovaldi in Those With HIV  AIDSmeds1 hour ago Bristol-Myers Hepatitis C Therapy With Sovaldi Meets Study Goals  4 Traders4 hours ago Bristol-Myers presents data on daclatasvir at Liver Meeting  Seeking Alpha1 day ago
[x]  

MYERS : Announces Reporting Date for 2015 First Quarter Results

Release date- 24042015 - Myers Industries, Inc. (NYSE: MYE) today announced that it intends to report financial results for the first quarter ended March 31, 2015 , on Friday, May 1, 2015 , before the market opens. The Company will host an ...
 4 Traders2 hours ago CVB Financial Corporation (CVBF) CEO Chris Myers on Q1 2015 Results - Earnings Call Transcript  Seeking Alpha2 days ago United States v. Allan Myers, Inc.  Environmental Law Institute3 days ago Myers Industries Announces Reporting Date for 2015 First Quarter Results; Conference Call Scheduled  Digital Journal3 days ago
[x]  

Bristol-Myers Squibb Popular Amongst Latest 13F Filers

Follow Comments Following Comments Unfollow Comments At Holdings Channel, we have reviewed the latest batch of the 24 most recent 13F filings for the 03/31/2015 reporting period, and noticed that Bristol-Myers Squibb Co. (NYSE: BMY) was held ...
 Forbes.com4 hours ago

EU recommends Opdivo as monotherapy for advance melanoma

Singapore: European Medicines Agency (EMA) has recommended granting a marketing authorisation for Bristol-Myers Squibb's Opdivo (nivolumab) as monotherapy for the treatment of adult patients with advanced melanoma. Melanoma is the most aggressive ...
 Bio Spectrum Asia9 hours ago EMA approves BMS Opdivo for advanced skin cancer  Pharmafocus5 hours ago European Medicines Agency recommends Opdivo for treatment of advanced melanoma  Pharmaceutical Business Review8 hours ago EMA recommends approval of Opdivo for treatment of advanced melanoma  PharmaBiz13 hours ago

Padres 3, Dodgers 1

Los Angeles San Diego ab r h bi ab r h bi Rollins ss 4 0 1 0 Myers cf 4 0 1 0 Ethier rf 4 0 1 0 Solarte 3b 2 0 0 0 AGnzlz 1b 4 0 0 0 Benoit p 0 0 0 0 Grandl c 3 0 0 0 Venale ph 1 0 0 0 JuTrnr 2b 3 0 1 0 Kimrel p 0 0 0 0 Crwfrd lf 3 0 0 0 Kemp rf 3 1 ...
 MySanAntonio18 hours ago - MLB - - BOTTOM 8TH - LOS ANGELES 1 SAN DIEGO 3 PITCHING: LOS - Carlos Frias(8th) VS. SDP - Joaquin Benoit(8th)  TickerTech.com19 hours ago - MLB - - BOTTOM 1ST - LOS ANGELES 0 SAN DIEGO 0 PITCHING: LOS - Scott Baker VS. SDP - Brandon Morrow  TickerTech.com21 hours ago

John Myers denies dodging tax on £6m income

HMRC has secured a tribunal win against John Myers for using a tax avoidance scheme. The former GMG Radio executive used the scheme to try and claim back millions of pounds of tax he paid whilst at GMG in 2005/2006. But after investigation by ...
 Radio Today3 hours ago Former board director at Guardian publisher John Myers tried to dodge massive tax bill  This is Money1 day ago

Bristol-Myers Squibb Earnings Preview: Yervoy, Opdivo And Eliquis In Focus

Bristol-Myers Squibb (NYSE:BMY) will report its Q1 2015 earnings on April 28th. We expect the company to report strong operational growth for the oncology business, a ramp up in sales of Eliquis, and the continued adoption of hepatitis C drug ...
 Trefis1 hour ago Earnings Increase Expected for Bristol-Myers Squibb  Forbes.com2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - myers
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less